Confirmation of transmission of the microsporidian parasite Enterocytozoon bieneusi in South Africa.
von Gottberg
A M
AM
Dini
L A
LA
Frean
J A
JA
Grimwood
A J
AJ
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy / Q000635:transmission*; D000328:Adult; D015766:Albendazole / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000969:Antinematodal Agents / Q000627:therapeutic use; D016360:Clostridioides difficile / Q000302:isolation & purification; D016785:Cryptosporidium parvum / Q000302:isolation & purification; D003967:Diarrhea / Q000382:microbiology; D005243:Feces / Q000382:microbiology; D005260:Female; D006801:Humans; D008463:Mebendazole / Q000627:therapeutic use; D008795:Metronidazole / Q000627:therapeutic use; D016816:Microsporida / Q000302:isolation & purification*; D016881:Microsporidiosis / Q000175:diagnosis / Q000188:drug therapy / Q000635:transmission*; D013019:South Africa; D013170:Spores / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D000969:Antinematodal Agents; D008795:Metronidazole; D008463:Mebendazole; D015766:Albendazole